"Triiodothyronine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
| Descriptor ID |
D014284
|
| MeSH Number(s) |
D06.472.931.740.385 D12.125.072.050.767.741.894
|
| Concept/Terms |
Triiodothyronine- Triiodothyronine
- T3 Thyroid Hormone
- Thyroid Hormone, T3
- Liothyronine
|
Below are MeSH descriptors whose meaning is more general than "Triiodothyronine".
Below are MeSH descriptors whose meaning is more specific than "Triiodothyronine".
This graph shows the total number of publications written about "Triiodothyronine" by people in this website by year, and whether "Triiodothyronine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 1 | 4 |
| 1995 | 0 | 4 | 4 |
| 1996 | 1 | 2 | 3 |
| 1997 | 4 | 2 | 6 |
| 1998 | 1 | 3 | 4 |
| 1999 | 3 | 5 | 8 |
| 2000 | 0 | 3 | 3 |
| 2001 | 1 | 7 | 8 |
| 2002 | 2 | 6 | 8 |
| 2003 | 1 | 4 | 5 |
| 2004 | 3 | 3 | 6 |
| 2005 | 4 | 1 | 5 |
| 2006 | 1 | 5 | 6 |
| 2007 | 2 | 3 | 5 |
| 2008 | 1 | 3 | 4 |
| 2009 | 5 | 6 | 11 |
| 2010 | 4 | 4 | 8 |
| 2011 | 3 | 3 | 6 |
| 2012 | 0 | 2 | 2 |
| 2013 | 3 | 4 | 7 |
| 2014 | 1 | 3 | 4 |
| 2015 | 4 | 3 | 7 |
| 2016 | 3 | 3 | 6 |
| 2017 | 3 | 1 | 4 |
| 2018 | 3 | 2 | 5 |
| 2019 | 3 | 1 | 4 |
| 2020 | 2 | 4 | 6 |
| 2021 | 5 | 2 | 7 |
| 2022 | 2 | 6 | 8 |
| 2023 | 1 | 4 | 5 |
| 2024 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Triiodothyronine" by people in Profiles.
-
Combined Levothyroxine and Propylthiouracil Treatment in Children with Monocarboxylate Transporter 8 Deficiency: A Multicenter Case Series of 12 Patients. Thyroid. 2024 Nov; 34(11):1435-1443.
-
Thyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil. J Clin Endocrinol Metab. 2024 Sep 16; 109(10):2504-2512.
-
A Cross-Sectional Analysis of Cardiovascular and Bone Health Care Utilization During Treatment With Thyroid Hormone. J Clin Endocrinol Metab. 2024 Feb 20; 109(3):e1143-e1150.
-
Impaired sensitivity to thyroid hormones is associated with albuminuria in the euthyroid population: results from NHANES. Hormones (Athens). 2024 Jun; 23(2):245-255.
-
Editorial: (Re)defining hypothyroidism: the key to patient-centered treatment. Front Endocrinol (Lausanne). 2024; 15:1369723.
-
Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism. J Clin Endocrinol Metab. 2023 11 17; 108(12):e1614-e1623.
-
Sustained Pituitary T3 Production Explains the T4-mediated TSH Feedback Mechanism. Endocrinology. 2023 11 02; 164(12).
-
Emerging Therapies in Hypothyroidism. Annu Rev Med. 2024 Jan 29; 75:307-319.
-
Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism? Endocr Pract. 2023 Jul; 29(7):581-588.
-
Serum Thyrotropin and Triiodothyronine Levels in Levothyroxine-treated Patients. J Clin Endocrinol Metab. 2023 05 17; 108(6):e258-e266.